AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1587377
Drug: Immunotherapy indicated
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy indicated but not received
Trial: 2876719
Drug: Alfentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil infusion (0.4 to 0.5 micrograms kg‐1 min‐1)
Trial: 2876719
Drug: Pethidine infusion
RxNorm normalized name: pethidine
DrugBank: Meperidine (DB00454)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pethidine infusion
Trial: 24139824
Drug: CaD (700
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CaD (700 mg calcium + 200 IU vitamin D)
Trial: 24139824
Drug: CaDEA (700
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CaDEA (700 mg calcium + 200 IU vitamin D + 12 IU vitamin E + 2,000 IU vitamin A)
Trial: 24139824
Drug: Ca (700
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ca (700 mg calcium)
Trial: 19616498
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate vaccine (PCV), three doses
Trial: 19616498
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate vaccine (PCV), two doses
Trial: 19616498
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate vaccine (PCV), one dose
Trial: 9497213
Drug: Endoscopic variceal
RxNorm normalized name: VARICELLA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic variceal ligation therapy (EVL)
Trial: 9497213
Drug: Endoscopic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic injection variceal sclerotherapy (EVS)
Trial: 9497213
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of EVL plus low-dose EVS
Trial: 7961545
Drug: Venlafaxine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (75 to 375 mg/day)
Trial: 7961545
Drug: Venlafaxine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (200 mg/day)
Trial: 7961545
Drug: Venlafaxine (201-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (201-300 mg/day)
Trial: 7961545
Drug: Venlafaxine (>
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (> 300 mg/day)
Trial: 31755939
Drug: Thrombin‐activatable fibrinolysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombin‐activatable fibrinolysis inhibitor activation peptide antigen
Trial: 21793899
Drug: Systemic administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic administration of carcinine
Trial: 21793899
Drug: Parabulbar, subconjunctival,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parabulbar, subconjunctival, and intravitreal injection of carcinine
Trial: 20642550
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg once daily)
Trial: 20642550
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg once daily) and Itraconazole (200 mg once daily)
Trial: 17451383
Drug: 2% minoxidil
RxNorm normalized name: MINOXIDIL 2 g in 100 mL TOPICAL LIQUID [2% Minoxidil hair growth serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% minoxidil solution twice daily for 12 months
Trial: 17451383
Drug: 0.025% alfatradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.025% alfatradiol solution once daily for 6 months, then 2% minoxidil for months 7-12
Trial: 7583900
Drug: Intra-articular buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular buprenorphine (0.30 mg)
Trial: 8104017
Drug: Ebastine 30
RxNorm normalized name: ebastine
DrugBank: Ebastine (DB11742)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ebastine 30 mg
Trial: 26501782
Drug: Time on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time on treatment
Trial: 22818804
Drug: Oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hygiene instruction (OHI) only
Trial: 22818804
Drug: OHI and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OHI and 0.2% chlorhexidine mouth rinse twice daily
Trial: 22818804
Drug: OHI, 0.2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OHI, 0.2% chlorhexidine mouth rinse twice daily, and assisted brushing twice weekly
Trial: 20922564
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (ZA) 4 mg IV, every 6 months
Trial: 17530360
Drug: Interferon-alpha2a plus
RxNorm normalized name: Fibroblast interferon
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alpha2a plus 15 mg/kg per day of ribavirin (6 MU/day for 4 weeks, then 3 MU/day for 44 weeks)
Trial: 17530360
Drug: Interferon-alpha2a plus
RxNorm normalized name: Fibroblast interferon
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alpha2a plus ribavirin plus 200 mg/day of amantadine (6 MU/day for 4 weeks, then 3 MU/day for 44 weeks)
Trial: 12588054
Drug: Interdisciplinary therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interdisciplinary therapy (102 subjects)
Trial: 8153377
Drug: Conventional fractionated
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional fractionated treatment
Trial: 8153377
Drug: Both CHART
RxNorm normalized name: Stachybotrys chartarum
DrugBank: Stachybotrys chartarum (DB10847)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both CHART and conventional treatment
Trial: 2537340
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg clomipramine (CMI)
Trial: 2537340
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg clomipramine (CMI)
Trial: 27836356
Drug: Senna (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Senna (maximum daily dose of 38.7mg)
Trial: 14988614
Drug: Intravenous tirofiban
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tirofiban infusion
Trial: 11863317
Drug: Hirudin-containing cream
RxNorm normalized name: hirudin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hirudin-containing cream (Hirudex cream; Hirudo medicinalis extract 280 UI/100 g) applied 3-4 times daily for 5 days
Trial: 9689372
Drug: Bupivacaine and
RxNorm normalized name: bupivacaine and meloxicam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine and morphine with epinephrine
Trial: 8743003
Drug: 0.5% betaxolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% betaxolol twice daily
Trial: 2541335
Drug: Acyclovir (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir (800 to 3200 mg per day, starting 6 hours before transplantation for 12 weeks)
Trial: 12113
Drug: Bromazepam (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromazepam (0.1 mg/kg b.w. i.v.)
Trial: 16882344
Drug: Carboplatin AUC
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin AUC 5 plus pegylated liposomal doxorubicin 30 mg/m2, every 3 weeks
Trial: 14990150
Drug: Hyperoxygen compound
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperoxygen compound sodium chloride solution (HCSCS)
Trial: 14990150
Drug: Control sodium
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control sodium chloride solution (CSCS)
Trial: 15001936
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine (group 1)
Trial: 15001936
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A vaccine (group 2)
Trial: 15001936
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine (group 3)
Trial: 8226141
Drug: Fast neutron
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast neutron radiation therapy (20.4 Gy in 12 fractions)
Trial: 3768575
Drug: Placebo (inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (inhaled aerosol described as a powerful new drug)
Trial: 3768575
Drug: Bronchoconstrictive suggestion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchoconstrictive suggestion (inhaled nebulized water described as likely to cause chest tightness and wheezing)
Trial: 3768575
Drug: Control (distilled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (distilled nebulized water inhaled without suggestion)
Trial: 28350929
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 + Calcium (2000 IU/d of vitamin D3 and 1500 mg/d of calcium)
Trial: 23303057
Drug: Hydrocortisone (HCT)
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone (HCT) 25 mg/day over 4 days
Trial: 23303057
Drug: Hydrocortisone (HCT)
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone (HCT) 100 mg single dose
Trial: 9493587
Drug: 90 anti-Xa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 anti-Xa IU x kg(-1) b.i.d. of the 10,250 IU preparation (treatment A)
Trial: 9493587
Drug: 180 anti-Xa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 180 anti-Xa IU x kg(-1) o.d. of the 20,500 IU preparation (treatment B)
Trial: 4583184
Drug: Ibuprofen 1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 1,200 mg daily
Trial: 21784296
Drug: Behavioral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral therapy (BT) protocol consisting of eight weekly sessions
Trial: 19627350
Drug: Oral health-promotion
RxNorm normalized name: Healthy Mama Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health-promotion approach
Trial: 16883311
Drug: G‐CSF and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF and GM‐CSF (5 x 2 microg/kg/day)
Trial: 16883311
Drug: G‐CSF and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF and GM‐CSF (2.5 x 2 microg/kg/day)
Trial: 16883311
Drug: G‐CSF (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF (5 microg/kg/day)
Trial: 16883311
Drug: G‐CSF plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF plus GM‐CSF
Trial: 9586615
Drug: Levofloxacin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levofloxacin (250 mg once daily for 7 to 10 days)
Trial: 9586615
Drug: Lomefloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lomefloxacin (400 mg once daily for 14 days)
Trial: 26028058
Drug: High-protein (HP)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-protein (HP) breakfast (350 kcal, 35 g protein)
Trial: 19283884
Drug: All-trans retinoyl
RxNorm normalized name: all-trans-retinol
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All-trans retinoyl glucuronide (RAG) administered orally to Group II (n 42), blood collected 4 hours after dosing.
Trial: 17719942
Drug: Prebiotic supplement
RxNorm normalized name: FlorastorSelect Gut Boost Daily Probiotic and Prebiotic Supplement Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prebiotic supplement (with calcium intake > or = 700 mg/d)
Trial: 15030839
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia (lidocaine hydrochloride 2% gel)
Trial: 15030839
Drug: Regional anesthesia
RxNorm normalized name: ACL6SP45 REGIONAL ANESTHESIA KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regional anesthesia (peribulbar or retrobulbar injection of lignocaine 2%)
Trial: 9390011
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) 0.03 mg/kg
Trial: 7886391
Drug: Loperamide (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide (16 mg, orally)
Trial: 7886391
Drug: Distilled water
RxNorm normalized name: Distilled Water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distilled water (intraluminal infusion)
Trial: 7886391
Drug: Loperamide (intraluminal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide (intraluminal infusion)
Trial: 3279743
Drug: Isosorbide-5-mononitrate (IS-5-MN)
RxNorm normalized name: Isosorbide 5-mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide-5-mononitrate (IS-5-MN) 20 mg 3 times a day or 50 mg in a sustained-release tablet
Trial: 3279743
Drug: Nifedipine 20
RxNorm normalized name: nifedipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 20 mg in a sustained-release tablet 3 times a day
Trial: 20220206
Drug: Choline intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline intake 300 mg/d
Trial: 20220206
Drug: Choline intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline intake 550 mg/d
Trial: 20220206
Drug: Choline intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline intake 1100 mg/d
Trial: 20220206
Drug: Choline intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline intake 2200 mg/d
Trial: 20220206
Drug: Choline intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline intake 300 mg/d and 550 mg/d
Trial: 10553933
Drug: Yeast-derived vaccine
RxNorm normalized name: YEAST CELL,LIVE DERIVATIVE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yeast-derived vaccine
Trial: 8572340
Drug: Propofol/Alfentanil combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol/Alfentanil combination
Trial: 1441044
Drug: Norfloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin (400 mg orally twice daily for 10-21 days)
Trial: 1441044
Drug: Ciprofloxacin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (500 mg orally every 12 hours for 14-21 days)
Trial: 21143904
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose rate (LDR) Ra‐226 brachytherapy (n = 4; median 70Gy)
Trial: 21143904
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose rate (HDR) Ir‐192 brachytherapy (n = 4; 60 Gy)
Trial: 16250032
Drug: Interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2b plus ribavirin 15 mg/kg/d
Trial: 30488303
Drug: Image-guided high-dose-rate
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Image-guided high-dose-rate (HDR) brachytherapy (iBT)
Trial: 17978833
Drug: Contrast water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast water therapy (CWT)
Trial: 12900682
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (NaHCO3; 0.3 g.kg−1)
Trial: 12900682
Drug: Sodium chloride
RxNorm normalized name: Sodium Chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium chloride (NaCl; 0.045 g.kg−1)
Trial: 11011709
Drug: Sequential bilateral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential bilateral PRK
Trial: 8450243
Drug: Nucleoside therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nucleoside therapy (zidovudine, 2',3'-dideoxyinosine, or both) for a mean of 20 months
Trial: 8450243
Drug: Nucleoside therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nucleoside therapy
Trial: 24805282
Drug: SONO (ultrasound-guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SONO (ultrasound-guided quadruple injection axillary block)
Trial: 24805282
Drug: STIM (nerve
FDA approved: no
EMA approved: no
PMDA approved: no
Description: STIM (nerve stimulation-guided triple injection axillary block)
Trial: 23186567
Drug: 0.9% NaCl
RxNorm normalized name: Trace Metals Additive in 0.9% NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% NaCl (sterile saline) solution
Trial: 20473257
Drug: Lower-dose corticosteroids
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower-dose corticosteroids
Trial: 20473257
Drug: Short-duration, high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-duration, high-dose glucocorticoid therapy
Trial: 20473257
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses for persistent ARDS
Trial: 17703218
Drug: Prelox (combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prelox (combination of L‐arginine aspartate and Pycnogenol)
Trial: 12422064
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg opipramol
Trial: 21577010
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg opipramol
Trial: 10325662
Drug: Active NSAID
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active NSAID (Piroxicam 20 mg)
Trial: 10325662
Drug: Active NSAID
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active NSAID (Meloxicam 15 mg)
Trial: 10325662
Drug: Active NSAID
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active NSAID (Meloxicam 22.5 mg)
Trial: 1770156
Drug: Triazolam 0.50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam 0.50 mg for 1, 6, and 12 nights
Trial: 1770156
Drug: Triazolam 0.50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam 0.50 mg for 12 nights
Trial: 1770156
Drug: Triazolam 0.50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam 0.50 mg for 1 and 6 nights
Trial: 27964756
Drug: Rituximab (RTX)
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab (RTX) 2 g
Trial: 27964756
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of RF, anti-CCP, and high serum IgG
Trial: 20025635
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg isoflavones (60 mg of genistein)
Trial: 18162021
Drug: Aripiprazole (20-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole (20-30 mg/day)
Trial: 18162021
Drug: Haloperidol (5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (5-10 mg/day)
Trial: 11546945
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil 120 mg once daily
Trial: 9128034
Drug: Low flow
RxNorm normalized name: high mallow flower extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low flow anesthesia (300 ml.min‐1 of oxygen, 300 ml.min‐1 of nitrous oxide or 400 ml.min‐1 of oxygen, 200 ml.min‐1 of nitrous oxide)
Trial: 9128034
Drug: High flow
RxNorm normalized name: Blood Set High Flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High flow anesthesia (2 l.min‐1 of oxygen, 4 l.min‐1 of nitrous oxide)
Trial: 8179457
Drug: Heparin protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin protocol (5000 U bolus, followed by 1680 U/h or 1240 U/h)
Trial: 3067749
Drug: Daily relaxation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily relaxation technique for 3 weeks
Trial: 18724648
Drug: Tretinoin microsphere
RxNorm normalized name: tretinoin microsphere
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin microsphere gel 0.04% applied once nightly for 12 weeks
Trial: 23633700
Drug: Vehicle gel
RxNorm normalized name: vehicle gel base no.61
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle gel (placebo)
Trial: 18724649
Drug: Tretinoin microsphere
RxNorm normalized name: tretinoin microsphere
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin microsphere gel 0.04%
Trial: 10563706
Drug: Concurrent therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent therapy with zidovudine, lamivudine, loviride and zalcitabine (T4)
Trial: 10563706
Drug: Cyclical therapy
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclical therapy with the same four drugs (C4)
Trial: 10563706
Drug: Concurrent zidovudine
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent zidovudine and lamivudine (T2)
Trial: 8688345
Drug: Ondansetron 16
RxNorm normalized name: ondansetron 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 16 mg suppository once daily
Trial: 8688345
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg tablets twice daily